Amundi’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Amundi’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,802	Closed	-$260K	–	2030
2022 Q3	$260K	Hold	3,802	–	–	﹤0.01%	1428
2022 Q2	$132K	Sell	3,802 -370	-9%	-$10.8K	﹤0.01%	1409
2022 Q1	$150K	Hold	4,172	–	–	﹤0.01%	1419
2021 Q4	$116K	Hold	4,172	–	–	﹤0.01%	1555
2021 Q3	$106K	Hold	4,172	–	–	﹤0.01%	1511
2021 Q2	$146K	Buy	+4,172	New	+$163K	﹤0.01%	1435

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Amundi's GBT Position: Q4 2022 in Review

Amundi sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 3,802 shares — an estimated $260K sold.

Amundi first reported a position in GBT in Q2 2021 and held it in 6 quarters. The position peaked at $260K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Amundi reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Amundi sold 3,802 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $260K.
Amundi first reported a position in Global Blood Therapeutics, Inc. in Q2 2021 and held it in 6 quarters.
Amundi's Global Blood Therapeutics, Inc. position peaked at $260K in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Amundi's 13F filing for Q4 2022, filed 14 Feb 2023.